New “six-point” statement about prostate cancer screening (redux)

Three weeks ago we mentioned a new six-point statement about PSA screening developed at a meeting in Melbourne, Australia. We would note that an updated set of information about this statement is now available on the BJU International web site. … READ MORE …

Prostate Cancer Roundtable comments on plethora of guidelines on screening

As many readers will be aware, there have been two new sets of guidance about screening for prostate cancer issued in the past few months — the most recent from the American Urological Association just a couple of weeks ago. … READ MORE …

ASTRO issues new white paper on best practices for safety, effectiveness of IGRT

Image-guided methods for targeting radiation therapy (IGRT) are crucial in the treatment of localized prostate cancer. ASTRO has now issued the final version of a new white paper addressing “best practices” to improve the safety and effectiveness of these types of technology in clinical practice. … READ MORE …

Nutritional guidance for cancer patients

According to a new article in the journal Nutrition and Cancer, “Consistent online dietary recommendations are lacking for patients during and after cancer treatment.” This will hardly come as a shock to many in the prostate cancer community, but an article like this one may help to initiate development of better guidelines. … READ MORE …

Image guidance technology and radiation therapy for localized prostate cancer

Prostate cancer patients who are to be treated with any type of intensity-modulated radiation therapy (IMRT) for localized prostate cancer today can be pardoned if they are confused by the many ways in which that radiation therapy can be aimed and targeted through the use of image guidance (IGRT) systems. The variety of methods is significant and growing. … READ MORE …

NICE publishes guidance on focal HIFU for the treatment of localized prostate cancer in UK

In the UK, the National Institute for Clinical Excellence (NICE) has just published guidance on the use of focal forms of high-intensity focused ultrasound (HIFU) for the treatment of (low- and intermediate-risk forms of) localized prostate cancer. … READ MORE …

Color Doppler ultrasound in the biopsy-based diagnosis of prostate cancer

A new report from an Italian clinical research team, and based on a randomized clinical trial of 300 patients, suggests that color Doppler ultrasound offers no significant benefit over standard “gray-scale” ultrasound in the biopsy-based diagnosis of prostate cancer — which is not going to please the advocates of color Doppler ultrasonography. … READ MORE …

AUA comments on FDA guidance on safe use of 5-ARIs

The American Urological Association (AUA) has written to the U.S. Food & Drug Administration (FDA) seeking modification of the FDA’s recent guidance on the use of 5α-reductase inhibitors like dutasteride and finasteride in the management of urologic conditions. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,119 other followers